Search Results - Rimvydas Norvilas
- Showing 1 - 1 results of 1
-
1
Case Report: Specific ABL-Inhibitor Imatinib Is an Effective Targeted Agent as the First Line Therapy to Treat B-Cell Acute Lymphoblastic Leukemia With a Cryptic NUP214::ABL1 Gene... by Egle Stukaite-Ruibiene, Rimvydas Norvilas, Rimvydas Norvilas, Vaidas Dirse, Sigita Stankeviciene, Goda Elizabeta Vaitkeviciene, Goda Elizabeta Vaitkeviciene
Published 2022Call Number: Loading…Connect to this object online.
Located: Loading…
Book